ArticleWomen's health reports (New Rochelle, N.Y.)2024
Linguistic Validation of a British-English Version of the SAMANTA Questionnaire and HMB-VAS Tool: A Step Toward Improved Diagnosis of Heavy Menstrual Bleeding.
Article in Women's health reports (New Rochelle, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Usefulness of the Heavy Menstrual Bleeding Diagnostic Tools SAMANTA Questionnaire and Heavy Menstrual Bleeding-Visual Analog Scale Tool for Iron Deficiency Screening: An Exploratory Analysis from the COLIBRI Study.Women's health reports (New Rochelle, N.Y.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heavy menstrual bleeding (HMB) is a common disorder interfering with physical, emotional and social domains, and overall quality of life (QoL). The Heavy Menstrual Bleeding-Visual Analog Scale (HMB-VAS) tool, including the VAS for menstrual bleeding intensity (VAS-Int) and the VAS for its interference with daily activities (VAS-Imp), is useful for HMB screening. The SAMANTA questionnaire (SAMANTA-Q) was developed and psychometrically validated in Spanish to easily identify women with HMB. However, these instruments have not been validated in other languages. This study seeks to linguistically validate the SAMANTA-Q and the HMB-VAS tool in British English. Methods: Linguistic validation was conducted following the principles laid out by the International Society for Health Economics and Outcomes Research (ISPOR). This process included two forward translations by two independent native English-speakers; reconciled version; two backward translations by two independent native Spanish-speakers; review and reconciliation; 60-minute cognitive debriefing interviews with women with HMB balanced by educational levels; analysis and integration of changes in the reconciled version; proofreading, and creation of the final version. Results: No major issues were found in the linguistic validation process. Overall, cognitive debriefing participants with HMB considered that the SAMANTA-Q and the HMB-VAS tool were easy to read, comprehensive, quick to answer, and covered most of the issues related to HMB. Conclusions: Linguistically validated British-English versions of the SAMANTA-Q and HMB-VAS tool are now available for clinical practice and research. These validated tools will be useful to easily diagnose excessive menstrual blood loss impacting on QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.